The Catalyst

Most Recent Posts


Today Show contributor Linda Carroll wrote a great article about the importance of detecting Alzheimer's disease earlier in life.


This week in Malaysia, the United States continues Trans-Pacific Partnership (TPP) negotiations with many of its most important Asia-Pacific trading partners. As we’ve discussed extensively on the Catalyst, through TPP the U.S.

07.16.13 | By Preet Bilinski

I’m not talking about a broken heart from love, but rather from heart disease.

07.15.13 | By John Castellani

A chronic disease is detrimental to more than just the person who has it – its impact ripples through the health care system and economy as a whole. According to research by the Robert Wood Johnson Foundation, 80 cents of every dollar spent on health care in the United States goes to treat chronic disease.


The increasing burden of chronic diseases, as well as potential solutions to the problem, were a major focus for us this week.


From cancer and diabetes to heart disease and hypertension, prevalence of chronic disease in America has reached epidemic proportions. In the U.S., 75 percent of our health care dollars go toward its treatment.

07.09.13 | By Stephanie Fischer

It was one year ago today that the Food and Drug Administration Safety and Innovation Act (FDASIA) was signed into law, reauthorizing the Prescription Drug User Fee Act (

07.09.13 | By John Castellani

Every day, our industry works to develop new medicines that extend and improve the quality of life for patients. As the Baby Boom generation enters retirement age, one critical health care issue that we must address is how to keep our nation’s seniors healthy. It’s a topic that I come across regularly in my role at PhRMA.


Research shows that properly adhering to medications is a major challenge, but patients who take their medications as prescribed are more likely to have better outcomes.


According to new research by Milliman, a leading actuarial consulting firm, only about 3.3 percent of Part D enrollees filled a prescription for at least one specialty drug in 2011, a very small portion of total Part D enrollme


In the future, we just might be able to control non-communicable diseases with our phones.

07.02.13 | By Preet Bilinski

We all know someone impacted by heart disease or stroke. Well that applies to the researchers working on medicines to combat these deadly diseases, as well. Not surprising when you consider that heart disease is the leading cause of death for both men and women, with someone dying from a heart disease related event every minute.


As we continue to explore health policy through our ‘Conversations’ forum, today we’re introducing the next question and encourage you to weigh in with your thoughts:

“Every day, thousands of Americans turn 65. How do we help ensure that the U.S. system is ready to meet their needs?

07.02.13 | By Sascha Haverfield, Ph.D.

As a recent update on implementation of the Prescription Drug User Fee Act (PDUFA) explained, a new review program for new molecular entity (NME) new drug applications (NDA) and original biologic license applications (BLA) was established under


CBS News featured a segment over the weekend on the value of new cancer treatments and how precision medicine, also known as personalized medicine, is changing the way patients receive care.

07.01.13 | By John Castellani

Last week, we introduced ‘Conversations,’ a new forum that provides experts, innovators, patients and other stakeholders an opportunity to share ideas through a live, ongoing dialogue about the future of health care.

07.01.13 | By John Castellani

We often discuss in the Catalyst the challenges and promise inherent in the drug discovery process and its impact on patients.


This week, we launched our “Conversations” forum as part of our larger goal of engaging a broad spectrum of thinkers, patient advocates, providers and manufacturers on their thoughts about pressing health care questions.


More than 9,600 websites that illegally sell potentially dangerous, counterfeit drugs to patients were targeted this week by a partnership that included INTERPOL, the FDA, international regulatory and law enforcement bodies, as well as pharmaceutical companies.

06.27.13 | By Josephine Martin

As communities across the country celebrate June as National LGBT Pride Month, it is important to acknowledge the unique health challenges facing the LGBT community. In an effort to better understand and address these challenges, the National Health Interview Survey for 2013 will include questions specifically related to the LGBT population.